Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
about
Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansCurcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial.Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs.Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial.Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN)Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trialsPotential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860
Q28075256-844786CB-972F-40CA-B627-429B188673A8Q37449908-953F8BA1-FCA8-46D1-A543-564ABF5E719BQ37678960-1DBDB638-A2A4-47C1-80EE-BAF16E228990Q38858879-2D720D75-CCF2-4770-A7C0-29E839D768DEQ39445103-CABC0801-E102-48CE-9AB8-EC9ED816C42FQ42669753-5CA0F8C7-B0A7-4093-A408-F9716F458AA3Q47107756-401FBFBB-663B-440D-915F-7C1010C8968DQ47280429-64EEE7C1-C5B7-4AF1-9094-14B3FD792D07Q47795127-06AD73AF-96FD-4C71-A3FE-3E9C65BDDCCFQ58734575-0DE5F291-E5DA-4302-93DD-1AC82CDFF23DQ58739768-2C1300AC-8149-4CBE-940D-BFA1D285E5A3Q58753073-02B4F088-BB03-465A-9ED1-D24C106F62BC
P2860
Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
type
label
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
prefLabel
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@ast
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
P2093
P2860
P1433
P1476
Fish Oil Supplements Lower Ser ...... : A Randomized Clinical Trial.
@en
P2093
Fu-Rong Shu
Jun-Li Chen
Man-Tian Mi
Qian-Yong Zhang
Shi-Hui Chen
Xiang-Long Zeng
Xiao-Lan Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0133496
P407
P577
2015-07-30T00:00:00Z